He (or rather MSB has - or rather Oaktree has - but essentially for the time being he has) a patent - Mesenchymal Stem Cells expressing TNF-alpha receptors.
He doesn't really have secrets from folk like me that can read the patents and the science papers he is really only keeping the non sciencey types in the dark - (the ignorant are trading with the ignorant why does that matter because its the non sciency types (which vastly outnumber the sciency types - in terms of voting and in terms of money behind shares) that set the management (kpis or no kpis) that sets that rate of progress.
Stupid in large amounts ends up hurting stupid and not stupid alike by reducing the rate of progress to a snails crawl.
- Forums
- ASX - By Stock
- MSB
- Ann: FDA Notifies Clinical Data Sufficient for Refiling aGVHD BLA
MSB
mesoblast limited
Add to My Watchlist
0.61%
!
$1.66

Ann: FDA Notifies Clinical Data Sufficient for Refiling aGVHD BLA, page-470
Featured News
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
|
|||||
Last
$1.66 |
Change
0.010(0.61%) |
Mkt cap ! $2.114B |
Open | High | Low | Value | Volume |
$1.66 | $1.69 | $1.64 | $5.790M | 3.482M |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
1 | 460 | $1.66 |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
$1.66 | 67181 | 6 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
1 | 460 | 1.655 |
1 | 30000 | 1.650 |
1 | 30000 | 1.645 |
1 | 4685 | 1.640 |
3 | 21682 | 1.630 |
Price($) | Vol. | No. |
---|---|---|
1.660 | 61181 | 4 |
1.665 | 1801 | 1 |
1.670 | 20000 | 1 |
1.675 | 19642 | 2 |
1.680 | 31450 | 4 |
Last trade - 16.10pm 11/07/2025 (20 minute delay) ? |
Featured News
MSB (ASX) Chart |
The Watchlist
VMM
VIRIDIS MINING AND MINERALS LIMITED
Rafael Moreno, CEO
Rafael Moreno
CEO
SPONSORED BY The Market Online